These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33888313)

  • 1. Commentary: Is angiotensin II a game changer for vasoplegia after cardiac surgery, or is the jury still out?
    Chatterjee S
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1415-1416. PubMed ID: 33888313
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
    Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.
    Papazisi O; Palmen M; Danser AHJ
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):739-748. PubMed ID: 33085026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II and Vasoplegia in Cardiac Surgery: Paradigm Changer or Costly Contender?
    Chow JH; Strauss E; Mazzeffi MA
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):59-60. PubMed ID: 32950345
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma Renin Activity Increases With Cardiopulmonary Bypass and is Associated With Vasoplegia After Cardiac Surgery.
    Montgomery ML; Gross CR; Lin HM; Ouyang Y; Levin MA; Corkill HE; El-Eshmawi A; Adams DH; Weiner MM
    J Cardiothorac Vasc Anesth; 2023 Mar; 37(3):367-373. PubMed ID: 36509636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
    Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].
    Durán Bruce M; Gomar Sancho C; Holguera JC; Muliterno Español E
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):246-53. PubMed ID: 24507583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
    Gilbert M; Lema G
    Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.
    Chow JH; Wittwer ED; Wieruszewski PM; Khanna AK
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1407-1414. PubMed ID: 33875258
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: Angiotensin II: Expanding the rescue options for vasoplegia.
    Augoustides JG
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1417-1418. PubMed ID: 33985809
    [No Abstract]   [Full Text] [Related]  

  • 12. Power for the Sickest: Vitamin C for Vasoplegia after Cardiac Surgery.
    Long MT; Hess AS; McCarthy DP; DeCamp MM
    J Cardiothorac Vasc Anesth; 2020 Apr; 34(4):1123. PubMed ID: 31623966
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.
    Wieruszewski PM; Nei SD; Maltais S; Schaff HV; Wittwer ED
    A A Pract; 2018 Aug; 11(4):96-99. PubMed ID: 29634537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
    Ortoleva J; Shapeton A; Vanneman M; Dalia AA
    J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2766-2775. PubMed ID: 31917073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoplegia during cardiac surgery: current concepts and management.
    Fischer GW; Levin MA
    Semin Thorac Cardiovasc Surg; 2010; 22(2):140-4. PubMed ID: 21092891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass.
    Pasero D; Berton AM; Motta G; Raffaldi R; Fornaro G; Costamagna A; Toscano A; Filippini C; Mengozzi G; Prencipe N; Zavattaro M; Settanni F; Ghigo E; Brazzi L; Benso AS
    J Endocrinol Invest; 2021 Jul; 44(7):1533-1541. PubMed ID: 33247422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
    Evans A; McCurdy MT; Weiner M; Zaku B; Chow JH
    Ann Thorac Surg; 2019 Jul; 108(1):e5-e7. PubMed ID: 30582924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for vasoplegia after coronary artery bypass and valve surgery.
    Bastopcu M; Sargın M; Kuplay H; Erdoğan SB; Yapıcı N; Aka SA
    J Card Surg; 2021 Aug; 36(8):2729-2734. PubMed ID: 34018257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery.
    Riha H; Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):736-8. PubMed ID: 21684764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.